المؤلفون: Hill K, Raney C, Jackson K, Murdock HM, Dawson E, Hamilton R, DeLisser H, Mamtani M, Aysola J

المصدر: Advances in Medical Education and Practice, Vol Volume 12, Pp 863-869 (2021)

مصطلحات موضوعية: education, underrepresented in medicine, minority, socioeconomic status, Special aspects of education, LC8-6691, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://www.dovepress.com/a-new-way-of-evaluating-effectiveness-of-urm-summer-pipeline-programs-peer-reviewed-fulltext-article-AMEP; https://doaj.org/toc/1179-7258

URL الوصول: https://doaj.org/article/95f7ced9d51f4febbeb77911e913b90e

المؤلفون: R. C. Lindsley, Eunice S. Wang, Christopher J. Gibson, Phani K. Davineni, Murdock Hm, Harrison Tsai, Annette S. Kim, Harris Mh, Nardi, Lukasz P. Gondek

مصطلحات موضوعية: Genetics, Myeloid, biology, Myelodysplastic syndromes, Myeloid leukemia, Disease, medicine.disease, Loss of heterozygosity, medicine.anatomical_structure, KMT2A, medicine, biology.protein, Tandem exon duplication, Allele

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b71c399b2caa3cd4bb07d57d14343436
https://doi.org/10.1101/2021.11.01.21265781

المؤلفون: Kah-Leong Lim, Monica Schenone, Jacqueline S. Garcia, Eunice S. Wang, Yingtian Xie, Henry W. Long, Eric S. Winer, Vivian J. Bardwell, R. C. Lindsley, Lukasz P. Gondek, Eva Johanna Schaefer, Marlise R. Luskin, Clifford A. Meyer, Richard Stone, Rahul S. Vedula, Annie Apffel, Martin Carroll, Emmalee R. Adelman, Murdock Hm, Steven A. Carr, Paloma Cejas, Iman Fares, Mario Figueroa, Huan Wang, Christopher J. Gibson, Gearhart

مصطلحات موضوعية: Myeloid, medicine.medical_treatment, Cancer, macromolecular substances, Biology, medicine.disease, Chromatin, Cell biology, Targeted therapy, Leukemia, medicine.anatomical_structure, medicine, PRC1, Gene, Function (biology)

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::7fecef0e63b276ce52721deb286ccafe
https://doi.org/10.1101/2021.03.08.433705

المؤلفون: Murdock Hm

المصدر: Southern medical journal. 47(12)

مصطلحات موضوعية: Counseling, Psychotherapy, medicine.medical_specialty, business.industry, Family medicine, Mental Disorders, medicine, MEDLINE, Humans, General Medicine, business, Psychiatry

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e20cd948aaa2f0f1ef3877765a965267
https://pubmed.ncbi.nlm.nih.gov/13216390

المؤلفون: Murdock HM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Ho VT; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Garcia JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.

المصدر: Frontiers in immunology [Front Immunol] 2024 Mar 20; Vol. 15, pp. 1359113. Date of Electronic Publication: 2024 Mar 20 (Print Publication: 2024).

نوع المنشور: Journal Article; Review; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/therapy , Leukemia, Myeloid, Acute*/complications , Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods , Graft vs Host Disease*/etiology , Graft vs Host Disease*/prevention & control, Humans ; Graft vs Leukemia Effect ; Recurrence

المؤلفون: Garcia JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Kim HT; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Murdock HM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Ansuinelli M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Brock J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Cutler CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Gooptu M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Ho VT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Koreth J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Nikiforow S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Romee R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Shapiro R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Bat-Erdene D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Ryan J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Contreras ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Fell G; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Lindsley RC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Antin JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

المصدر: Blood advances [Blood Adv] 2024 Feb 27; Vol. 8 (4), pp. 978-990.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/drug therapy , Graft vs Host Disease*/etiology , Graft vs Host Disease*/prevention & control , Sulfonamides* , Bridged Bicyclo Compounds, Heterocyclic*, Humans ; Transplantation Conditioning ; Transplantation, Homologous ; Azacitidine/therapeutic use

المؤلفون: Aysola J; Penn Medicine Center for Health Equity Advancement, Office of the Chief Medical Officer, University of Pennsylvania Health System, Philadelphia, PA 19104, United States.; Office of Inclusion, Diversity, and Equity, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, United States.; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA 19104, United States.; Department of Medicine, Perelman School of Medicine, University of PA, Philadelphia, PA 19104, United States.; Department of Pediatrics, Perelman School of Medicine, University of PA, Philadelphia, PA 19104, United States., Murdock HM; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States., Lett E; Penn Medicine Center for Health Equity Advancement, Office of the Chief Medical Officer, University of Pennsylvania Health System, Philadelphia, PA 19104, United States.; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA 02115, United States., Williams C; MedStar Georgetown University Hospital, Washington, DC 20007, United States., Wade R Jr; Department of Pediatrics, Perelman School of Medicine, University of PA, Philadelphia, PA 19104, United States.; Division of General Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA 19178, United States., Higginbotham EJ; Office of Inclusion, Diversity, and Equity, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, United States.; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA 19104, United States.; Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, United States.

المصدر: Epidemiologic reviews [Epidemiol Rev] 2023 Dec 20; Vol. 45 (1), pp. 140-145.

نوع المنشور: Review; Journal Article

بيانات الدورية: Publisher: Country of Publication: United States NLM ID: 7910703 Publication Model: Print Cited Medium: Internet ISSN: 1478-6729 (Electronic) Linking ISSN: 0193936X NLM ISO Abbreviation: Epidemiol Rev Subsets: MEDLINE

مواضيع طبية MeSH: Goals* , Health Facilities*, Humans ; Learning ; Emotions

المؤلفون: Rapaport F; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Center for Clinical and Translational Science, The Rockefeller University, New York, NY, USA., Seier K; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Neelamraju Y; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA., Hassane D; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Baslan T; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gildea DT; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA., Haddox S; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA., Lee T; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Murdock HM; Division of Hematology and Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Sheridan C; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Thurmond A; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA., Wang L; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Carroll M; Division of Hematology and Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Cripe LD; Simon Cancer Center, Indiana University, Indianapolis, IN, USA., Fernandez H; Department of Malignant Hematology & Cellular Therapy, Moffitt Cancer Center, Tampa, FL, USA., Mason CE; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.; The WorldQuant Initiative for Quantitative Prediction, Weill Cornell Medicine, New York, USA., Paietta E; Montefiore Medical Center, Bronx, NY, USA., Roboz GJ; Weill Cornell Medicine and The New York Presbyterian Hospital, New York, NY, USA., Sun Z; Dana-Farber Cancer Institute, Boston, MA, USA., Tallman MS; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zhang Y; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gönen M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Levine R; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Melnick AM; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Kleppe M; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Garrett-Bakelman FE; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA. fg5q@virginia.edu.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA. fg5q@virginia.edu.; Department of Medicine, University of Virginia, Charlottesville, VA, USA. fg5q@virginia.edu.; University of Virginia Cancer Center, Charlottesville, VA, USA. fg5q@virginia.edu.

المصدر: Blood cancer journal [Blood Cancer J] 2023 Jul 06; Vol. 13 (1), pp. 103. Date of Electronic Publication: 2023 Jul 06.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Murdock HM; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Ehrie J; Department of Psychiatry, Columbia University, New York, NY, USA., Bennett NL; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Kogan JR; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

المصدر: Diagnosis (Berlin, Germany) [Diagnosis (Berl)] 2023 Apr 21; Vol. 10 (3), pp. 313-315. Date of Electronic Publication: 2023 Apr 21 (Print Publication: 2023).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: de Gruyter Country of Publication: Germany NLM ID: 101654734 Publication Model: eCollection Cited Medium: Internet ISSN: 2194-802X (Electronic) Linking ISSN: 2194802X NLM ISO Abbreviation: Diagnosis (Berl) Subsets: MEDLINE

مواضيع طبية MeSH: Students, Medical*, Humans ; Learning ; Internal Medicine

المؤلفون: Rapaport F; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Center for Clinical and Translational Science, The Rockefeller University, New York, NY, USA., Seier K; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Neelamraju Y; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA., Hassane D; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Baslan T; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gildea DT; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA., Haddox S; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA., Lee T; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Murdock HM; Division of Hematology and Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Sheridan C; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Thurmond A; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA., Wang L; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Carroll M; Division of Hematology and Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Cripe LD; Simon Cancer Center, Indiana University, Indianapolis, IN, USA., Fernandez H; Department of Malignant Hematology & Cellular Therapy, Moffitt Cancer Center, Tampa, FL, USA., Mason CE; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.; The WorldQuant Initiative for Quantitative Prediction, Weill Cornell Medicine, New York, USA., Paietta E; Montefiore Medical Center, Bronx, NY, USA., Roboz GJ; Weill Cornell Medicine and The New York Presbyterian Hospital, New York, NY, USA., Sun Z; Dana-Farber Cancer Institute, Boston, MA, USA., Tallman MS; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zhang Y; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gönen M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Levine R; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Melnick AM; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Kleppe M; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Garrett-Bakelman FE; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA. fg5q@virginia.edu.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA. fg5q@virginia.edu.; Department of Medicine, University of Virginia, Charlottesville, VA, USA. fg5q@virginia.edu.; University of Virginia Cancer Center, Charlottesville, VA, USA. fg5q@virginia.edu.

المصدر: Blood cancer journal [Blood Cancer J] 2022 Sep 23; Vol. 12 (9), pp. 137. Date of Electronic Publication: 2022 Sep 23.

نوع المنشور: Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/diagnosis , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics, Female ; Humans